{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:24Z","timestamp":1786118904130,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/wno.0b013e318175d206","type":"journal-article","created":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T03:13:59Z","timestamp":1220238839000},"page":"235-236","source":"Crossref","is-referenced-by-count":12,"title":["Positive Apraclonidine Test Within Two Weeks of Onset of Horner Syndrome Caused by Carotid Artery Dissection"],"prefix":"10.1097","volume":"28","author":[{"given":"Brenda L","family":"Bohnsack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared W","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-16-20210126","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0024-3205(90)90132-B","article-title":"Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study.","volume":"46","author":"Ritz","year":"1990","journal-title":"Life Sci"},{"key":"R3-16-20210126","first-page":"69","article-title":"Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome.","volume":"25","author":"Kardon","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"R4-16-20210126","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archopht.122.2.276","article-title":"The use of apraclonidine in the diagnosis of Horner syndrome in pediatric patients.","volume":"122","author":"Bacal","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R5-16-20210126","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archopht.121.8.1201","article-title":"The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome.","volume":"121","author":"Brown","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R6-16-20210126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajo.2006.04.052","article-title":"Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.","volume":"142","author":"Chen","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R7-16-20210126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/jop.2006.22.182","article-title":"Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of Horner syndrome in pediatric patients.","volume":"22","author":"Chen","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"R8-16-20210126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/014556130708600508","article-title":"Pharmacologic reversal of Horners syndrome-related ptosis with apraclonidine.","volume":"86","author":"Chu","year":"2007","journal-title":"Ear Nose Throat J"},{"key":"R9-16-20210126","first-page":"83","article-title":"Topical apraclonidine in the diagnosis of suspected Horner syndrome.","volume":"25","author":"Freedman","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"R10-16-20210126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.iop.0000196322.05586.6a","article-title":"Effect of 0.5% apraclonidine on ptosis in Horner syndrome.","volume":"22","author":"Garibaldi","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R11-16-20210126","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bjo.2005.074492","article-title":"The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.","volume":"89","author":"Koc","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R12-16-20210126","first-page":"951","article-title":"Ocular effects of apraclonidine in Horner syndrome.","volume":"118","author":"Morales","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R13-16-20210126","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/archopht.1987.01060090063028","article-title":"The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers.","volume":"105","author":"Abrams","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R14-16-20210126","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(86)90070-5","article-title":"Dilute solutions of phenylephrine and pilocarpine in the diagnosis of disordered autonomic innervation of the iris: observations in normal subjects, and in the syndromes of Horner and Holmes-Adie.","volume":"73","author":"Ramsay","year":"1986","journal-title":"J Neurol Sci"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNO.0b013e318175d206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:04:07Z","timestamp":1786035847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041327-200809000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e318175d206","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}